The second major mechanism is angiogenesis: the formation of new blood vessels
Data from the ORION study, presented at the Obesity Medicine Associations 2026 annual conference, showed that oral semaglutide 25 mg was associated with significantly greater mean weight loss than orforglipron in a population-adjusted indirect treatment comparison
Some of the well-known ones include: Ozempic (semaglutide): Approved in 2017 for type 2 diabetes, also commonly used off-label for weight management
You may need to check glucose levels regularly while on this treatment
The most common side effects include nausea, diarrhea, constipation, headache, vomiting, and low blood sugar
Although some studies have found that GIP on its own can trigger weight gain, when combined with GLP-1 agonists, it has been found to have profound weight loss benefits